One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1002/hon.33_2879
Copy DOI Journal: Hematological oncology |  Publication Date: Jun 1, 2021 |
 Citations: 5 |
Affiliation: St James's University Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, Presbyterian Hospital, Cornell University, Medical University of Lodz, Mayo Clinic, Jacksonville College, Hovon, University of Pennsylvania, Moffitt Cancer Center, University of Ulm, University of California, Irvine, Hospital Universitario Puerta de Hierro Majadahonda, University of Debrecen, The Ohio State University, Istanbul University, Normandie Université, University of Rouen, AstraZeneca (United States), IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, University of Melbourne, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, The Maria Sklodowska-Curie National Research Institute of OncologyFIRST RESULTS OF A HEAD‐TO‐HEAD TRIAL OF ACALABRUTINIB VERSUS IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
